Nitric oxide (NO) may mediate some of the toxic effects of the excitatory amino acid (EAA) glutamate when there is overactivation of the N-methyl-D-aspartate (NMDA) receptor. In the developing rodent nervous system, NMDA neurotoxicity peaks at postnatal day 7. To assess whether NO toxicity exhibits a similar developmental profile, we injected the NO generator sodium nitroprusside into the immature and adult rodent hippocampal formation and striatum, using a dose known to damage the adult nervous system. Contrary to our expectations, we found the immature brain highly resistant to the toxic effects of sodium nitroprusside.
A recent report demonstrated that intracerebral injections of sodium nitroprusside, a compound that generates nitric oxide (NO), produce focal necrotic lesions in the adult rat hippocampus [19] . Evaluation of nitroprusside neurotoxicity was prompted by a growing body of evidence that NO has intrinsic neurotoxic properties and mediates the neurotoxic effects of the excitatory amino acid (EAA) neurotransmitter glutamate. NO is generated by the catalysis of arginine to citrulline by nitric oxide synthase (NOS) [17, 20] ; in neurons, NOS is a calmodulin-dependent enzyme [2] which is activated by calcium influx following N-methyl-D-aspartate (NMDA) receptor stimulation [2, 9] . Excessive NMDA receptor activation, by increased synaptic concentrations of endogenous glutamate or by experimentally administered NMDA agonists, initiates a cascade of events resulting in cell death [5] . Evidence that NO generation contributes to EAA neurotoxicity is provided by the observation that chelators of NO prevent glutamate-induced cell death in rat cortical cultures [6] , and by reports that inhibitors of NOS prevent EAA-induced neuronal damage both in vitro [6, 14] and in vivo [8] and in some models of cerebral hypoxic-ischemic injury [3, 15, 22, 23] . In certain experimental paradigms, these same inhibitors may limit the neurotoxicity of the NMDA agonist quinolinic acid in vivo [28] , but paradoxical enhancement of toxicity has also been reported [10] .
Considerable experimental data indicate that developmental stage influences CNS susceptibility to EAA agonist neurotoxicity. For example, although the immature rodent brain is resistant to kainate [4], it is highly vulnerable to NMDA toxicity; susceptibility to NMDA-mediated forebrain injury peaks at postnatal day 7 (P7) [21] . Whether NO itself is toxic in the developing nervous system is unknown. If NO mediates NMDA-induced brain injury, then it might be expected that the developing brain would be particularly susceptible to nitroprusside neurotoxicity. To test this hypothesis, we performed direct intrahippocampal and intrastriatal injections of sodium nitroprusside in P7 and adult rats, and assessed the severity of resulting brain injury in animals sacrificed 5 days later.
Eleven unsexed P7 rats (8-12 g) and 10 adult male rats (175 200 g; Sprague-Dawley, Harlan) were used. All animal use procedures were in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the University of Michigan Committee on the Use and Care of Animals. Sodium nitroprusside was obtained from Sigma (St Louis, MO).
Ether anesthesia was used for both perinatal and adult rat surgery. Solutions of nitroprusside (dissolved in room-temperature sodium phosphate buffer, pH 7.4) were prepared immediately prior to surgery to minimize exposure to light. Using a 30-gauge cannula, seven P7 rats (three and four animals/experiment, in two independent experiments using different batches of nitroprusside) and four adult rats each received 1 -/A injections of 33 nmol sodium nitroprusside into the CA3 subfield of the right hippocampal formation; four P7 and six adult animals received injections of the same volume of sodium nitroprusside in the right striatum. The anesthetized P7 animals were positioned with bregma and lambda in the same horizontal plane and stereotaxic coordinates for the striatum, relative to bregma, were AP -0.2 ram, ML 2.5 mm, DV 3.5 mm; for CA3, coordinates were: AP -1.7 mm, ML 2.7 ram, and DV 2.7 mm. In the adults, with the incisor bar at -2.3 mm, CA3 coordinates were, relative to bregma AP -4.0 ram, ML -3.0 mm and DV 3.6 mm from the cortical surface; the striatum was targeted AP +1.0 mm and ML 2.5 mm from bregma and 5.0 mm ventral from the surface of the brain. Following injections, the cannula was left in place for one minute. Two of the adult rats died during surgery. Controls receiving intraparenchymal injections of vehicle were not included in this study since, in previous experiments using our injection methods, phosphate buffer produced only subtle well-circumscribed lesions adjacent to the needle tract in both the immature and adult brain. Animals were sacrificed 5 days later by decapitation, the brains quickly removed and frozen on powdered dry ice. The brains were stored at -70°C until they were sectioned.
For histological evaluation, 20-¢tm frozen coronal sections obtained at 80-/~m intervals were thaw-mounted on gelatin-coated glass slides. Following a 2-day exposure to paraformaldehyde vapor at room temperature, sections were stained for Nissl substance using Cresyl violet.
Assessment of the lesions was made using a dissecting stereoscope.
In brains of adult rats that had received striatal injections of sodium nitroprusside there were discolored areas of necrosis, -3 by 3 mm, on the ventral surface of the brain in the anterior temporal region. These regions represent the most ventral extent of the lesion. In brains of animals that received hippocampal injections, slight depressions of the overlying cortical surface were evident. Gross inspection of the immature rat brains following injections into either CA3 or the striatum revealed no obvious abnormalities.
Injections of sodium nitroprusside into adult CA3 resulted in marked atrophy of the entire hippocampus with loss of both pyramidal and granule cells (Fig. IA) . In all cases, there was evidence of variable degrees of neuronal necrosis in the adjacent thalamus and the overlying cortex. Of particular interest was the sparing of the corpus callosum in those sections in which there were both hippocampal and cortical lesions. Injections of nitroprusside were also destructive when applied to the striatum (Fig. 1B) . These lesions typically involved approximately one half or greater of the striatum at the center of the lesion and extended through its entire rostrocaudal extent. Some of the lesions also extended ventrally into nucleus accumbens and into cortical regions laterally. The corpus callosum was again spared and appeared to limit the extent of injury.
In contrast with the extensive abnormalities in the adult, in the younger animals no obvious lesions were produced by sodium nitroprusside injection into either the hippocampus or striatum (Fig. 2) . In five of the seven animals that had received injections in the hippocampus, minimal mechanical damage was noted around the cannula tract. Features of mechanical injury ranged from small necrotic cysts ( Fig. 2A, asterisk) along or at the tip of the needle tract to focal disruption of the CA 1 pyram- idal cell layer by the needle (Fig. 2B, arrowhead) . In four of these five animals, there was no other evidence of injury. In two animals (including one with a mechanical lesion and one in which no tract was evident), there were subtle discrete lesions in the pyramidal cell layer consisting of focal cell loss without gliosis ( Fig. 2A,C , arrowheads). In one of seven, neither the cannula tract nor focal cell loss was detected. In one of the four animals that had received an injection into the striatum, the mechanical damage by the cannula resulted in a narrow region of disrupted striatal morphology adjacent to the lateral ventricle (Fig. 2D, arrowheads) ; in two of the four animals, the cannula tract was identified exiting the corpus callosum (Fig. 2B,C) , and in one brain (not shown) there was no discernible evidence of injury.
These results demonstrate that direct intracerebral injection of sodium nitroprusside is not neurotoxic in the developing rat brain. It is unlikely that our findings can be explained by failure of the immature brain to generate NO since it has been shown that nitroprusside stimulates the formation of NO in slices of neonatal cerebellum [26] and that the NMDA agonist quinotinate [28] inereases striatal production of NO in P7 rats. Several mechanisms could account for this significant developmental difference in susceptibility to nitroprusside neurotoxicity. The findings reported herein are somewhat discrepant with the results of two groups who independently demonstrated that pretreatment with the NOS inhibitor L-N';-nitroarginine (NO-Arg) was neuroprotective in a focal stroke model in the 7-day-old rat [ 11,271. This finding suggests that endogenous NO production at this developmental stage was a mediator of ischemic neuronal injury. It is conceivable that hypoxia/ischemia alters the intracellular milieu in such a way as to augment NO toxicity, e.g., by increasing production of superoxide anions, which, coupled with hypoxialischemia induced NMDA receptor activation and subsequent NO release, would favor the production of the peroxynitrite intermediate. Alternatively, the neuroprotective effects of an NOS inhibitor may have been attributable to inhibition of non-neuronal NO production by endothelial cells or glia, or to induced hypothermia which itself is neuroprotective.
The observation that developmental stage influences susceptibility to nitroprusside neurotoxicity may help explain some of the discrepancies in results of studies on the effects of NOS inhibitors on glutamate-induced toxicity in cortical cultures [12, 24, 25] 
